Alcalay RN, Levy OA, Waters C, Fahn S, Ford B, Kuo SH, Mazzoni P, Marder K, Pauciulo MW, Nichols WC, Gan-Or Z, Rouleau GA, Chung WK, Wolf P, Oliva P and Zhang XK. Glucocerebrosidase activity in Parkinson disease with and without GBA mutations. Brain. 2015. PubMed
Blog
PARK16 haplotypes and the importance of protective genetic factors in Parkinson’s disease
Gan-Or Z. PARK16 haplotypes and the importance of protective genetic factors in Parkinson’s disease. Journal of Human Genetics. 2015. (letter). PubMed
Analysis of functional GLO1 variants in the BTBD9 locus and Restless Legs Syndrome
Gan-Or Z, Zhou S, Ambalavanan A, Leblond CS, Xie P, Johnson A, Spiegelman D, Allen RP, Earley CJ, Desautels A, Montplaisir JY, Dion PA, Xiong L and Rouleau GA. Analysis of functional GLO1 variants in the BTBD9 locus and Restless Legs Syndrome. Sleep Medicine. 2015. PubMed
LRRK2 mutations in Parkinson disease; a sex effect or lack thereof? A meta-analysis
Gan-Or Z, Leblond CS, Mallett V, Orr-Urtreger A, Dion PA and Rouleau GA. LRRK2 mutations in Parkinson disease; a sex effect or lack thereof? A meta-analysis.Parkinsonism and Related Disorders. 2015. PubMed
Parkinson’s disease genetic loci in Rapid Eye Movement Sleep Behavior Disorder
Gan-Or Z, Girard SL, Noreau A, Leblond CS, Gagnon JF, Arnulf I, Mirarchi C, Dauvilliers Y, Desautels A, Mitterling T, Cochen De Cock V, Frauscher B, Monaca C, Hogl B, Dion PA, Postuma RB, Montplaisir JY and Rouleau GA. Parkinson’s disease genetic loci in Rapid Eye Movement Sleep Behavior Disorder. Journal of Molecular Neuroscience. 2015. PubMed
A Homozygous Mutation in SLC1A4 in siblings with severe intellectual disability and microcephaly
Srour M, Hamdan FF, Gan-Or Z, Labuda D, Nassif C, Oskoui M, Gana-Weisz M, Orr-Urtreger A7, Rouleau GA and Michaud JL. A Homozygous Mutation in SLC1A4 in siblings with severe intellectual disability and microcephaly. Clinical Genetics. 2015. PubMed
Genetic markers of Restless Legs Syndrome in Parkinson Disease
Gan-Or Z, Alcalay RN, Bar-Shira A, Leblond CS, Postuma RB, Ben-Shachar S, Waters C, Johnson A, Levy OA, Mirelman A, Gana-Weisz M, Dupre N, Montplaisir JY, Giladi N, Fahn S, Xiong L, Dion PA, Orr-Urtreger A and Rouleau GA. Genetic markers of Restless Legs Syndrome in Parkinson Disease. Parkinsonism and Related Disorders. 2015. PubMed
Differential effects of severe vs. mild GBA mutations on Parkinson disease
Gan-Or Z, Amshalom I, Kilarski L.L, Bar-Shira A, Gana-Weisz M, Mirelman A, Marder K, Bressman, Giladi N, and Orr-Urtreger A. Differential effects of severe vs. mild GBA mutations on Parkinson disease. Neurology. 2015. PubMed
CHRNB3 c.-57A>G functional promoter change affects Parkinson’s disease and smoking
(*equal contribution) Bar-Shira A*, Gana-Weisz M*, Gan-Or Z*, Giladi E, Giladi N and Orr-Urtreger A. CHRNB3 c.-57A>G functional promoter change affects Parkinson’s disease and smoking. Neurobiology of Aging. 2014. PubMed
The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease
Gan-Or Z, Ozelius LJ, Bar-Shira A, Saunders-Pullman R, Mirelman A, Kornreich R, Gana-Weisz M, Raymond D, Rozenkrantz L, Deik A, Gurevich T, Gross SJ, Schreiber-Agus N, Giladi N, Bressman SB, and Orr-Urtreger A. The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease. Neurology. 2013. PubMed